Searchable abstracts of presentations at key conferences in endocrinology

ea0016p317 | Endocrine tumours | ECE2008

The prognostic factors in adrenocortical carcinoma

Przybylik-Mazurek Elwira , Hubalewska-Dydejczyk Alicja , Kuzniarz Sylwia , Lubaszewska Katarzyna , Huszno Bohdan

Adrenocortical carcinoma (ACC) is a rare neoplasm with poor prognosis. Patients present signs of hormone excess: virilisation, Cushing’s syndrome or only enlarged abdominal mass. Incidentally ACC can be also detected in the ultrasonography. Some of ‘non-hypersecretory’ ACCs can produce non-bioactive hormones steroid precursors or not very big amount of them and sometimes patients present subclinical Cushing’s symptoms. Surgery and adjuvant radiotherapy and ...

ea0020p211 | Endocrine tumours and neoplasia | ECE2009

Clinical feature and genetic testing in patients with multiple endocrine neoplasia syndrome type 2

Przybylik-Mazurek Elwira , Hubalewska-Dydejczyk1 Alicja , Pach Dorota , Kuzniarz Sylwia , Jarzab Barbara , Gubala Elzbieta , Pawlaczek Agnieszka , Oczko-Wojciechowska Malgorzata

Background: Multiple endocrine neoplasia syndrome type 2 (MEN2) is a rare disease characterised by inherence in each patient medullary thyroid carcinoma (MTC), pheochromocytoma and in type MEN 2a primary hyperparathyroidism, in type MEN2b marfanoid habitus and neurofibromas. Mutation in RET proto-oncogene at chromosome 10 is a molecular cause of MEN2 syndrome.Methods: Eighteeen patients with MEN2 syndrome were enrolled: (10 women and 8 men) mean age 22&#...